Abstract:Background Photodynamic therapy (PDT) with 5-aminolevulinic acid (ALA) is a reliable treatment for actinic keratosis (AK), but its effect needs to be enhanced in thick lesions. Plum-blossom needle is a traditional Chinese cost-effective instrument for enhancing the transdermal delivery of ALA. However, whether it could improve the efficacy of AK treatment has not yet been investigated. Objective To compare the efficacy and safety of plum-blossom needle–assisted PDT in facial AK in the Chinese population. Methods In this multicenter, prospective study, a total of 142 patients with AKs (grades I–III) were randomized into the plum-blossom needle–assisted PDT group (P-PDT) and control PDT group (C-PDT). In the P-PDT group, each AK lesion was tapped vertically by a plum-blossom needle before the application of 10% ALA cream. In the C-PDT group, each lesion was only wiped with regular saline before ALA cream incubation. Then, 3 hours later, all the lesions were irradiated with light-emitting diode (LED) at a wavelength of 630 nm. PDT was performed once every 2 weeks until all lesion patients achieved complete remission or completed six sessions. The efficacy (lesion response) and safety (pain scale and adverse events) in both groups were evaluated before each treatment and at every follow-up visit at 3-month intervals until 12 months. Results In the P-PDT and C-PDT groups, the clearance rates for all AK lesions after the first treatment were 57.9% and 48.0%, respectively ( P < 0.05). For grade I AK lesions, the clearance rates were 56.5% and 50.4%, respectively ( P = 0.34). For grade II AK lesions, the clearance rates were 58.0% and 48.9%, respectively ( P = 0.1). For grade III AK lesions, the clearance rates were 59.0% and 44.2%, respectively ( P < 0.05). Moreover, grade III AK lesions in the P-PDT group required fewer treatment sessions ( P < 0.05). There was no significant difference in the pain score between the two groups ( P = 0.752). Conclusion Plum-blossom needle tapping may enhance the efficacy of ALA-PDT by facilitating ALA delivery in the treatment of AK.

Assessment of 5‐aminolaevulinic Acid Photodynamic Therapy (ALA‐PDT) in Chinese Patients with Actinic Keratosis: Correlation of Dermoscopic Features with Histopathology

Therapeutic and fluorescence evaluation of 20% 5-aminolevulinic acid-mediated photodynamic therapy in actinic keratosis

5-Aminolaevulinic acid-based photodynamic therapy for actinic keratosis in Chinese patients: A prospective multicenter study

Dermoscopic Monitoring for Treatment and Follow-Up of Actinic Keratosis with 5-Aminolaevulinic Acid Photodynamic Therapy

Plum-blossom needle tapping enhances the efficacy of ALA photodynamic therapy for facial actinic keratosis in Chinese population: a randomized, multicenter, prospective, and observer-blind study

Topical Photodynamic Therapy with Different Forms of 5-Aminolevulinic Acid in the Treatment of Actinic Keratosis

A Combination of Laser-Assisted ALA-PDT for Squamous Cell Carcinoma in Situ and Field-Directed ALA-PDT for Actinic Keratosis.

Comparison of Efficacy, Adverse Effects and Costs Between 20 % ALA-PDT and 10 % ALA-PDT for the Treatment of Actinic Keratosis in Chinese Patients

Modified Painless Photodynamic Therapy for Actinic Keratosis in China

Clinical effect and safety of 5-aminolevulinic acid photodynamic therapy in the treatment of nose actinic keratosis

Modified painless photodynamic therapy for facial multiple actinic keratosis in China: A prospective split‐face control study

Long-term Improvement on Photoaging after ALA Photodynamic Therapy for Actinic Keratosis: A Retrospective Study.

Efficacy and safety of microneedling, fractional CO2 laser, and cryotherapy combined with 5-aminolevulinic acid photodynamic therapy in the treatment of actinic keratosis: A multicenter prospective randomized controlled study

Topical 5-Aminolevulinic Acid-Mediated Photodynamic Therapy for Oral Verrucous Hyperplasia, Oral Leukoplakia and Oral Erythroleukoplakia

Photodynamic Therapy with 5-Aminolevulinic Acid Patch for the Treatment of Actinic Keratosis

5-Aminolaevulinic acid patch photodynamic therapy for the treatment of actinic keratoses: preliminary results from an Italian study in the real-life setting

High efficacy of red light photodynamic therapy with 10 % aminolevulinic acid gel irrespective of the extent of keratinocyte atypia in actinic keratosis – exploratory post-hoc analysis of three pivotal phase III trials

The Application of High-Frequency Ultrasonography in Post-Therapeutic Assessment of Actinic Keratosis After Photodynamic Therapy

Inflammation burst after 5-aminolevulinic acid-photodynamic therapy for the treatment of actinic keratosis complicating rosacea: A case report

Home- vs clinic-based daylight photodynamic therapy with 5-aminolevulinic acid nanoemulsion (BF-200 ALA) for actinic keratosis: A randomized, single-blind, prospective study

Evaluation of Photodynamic Therapy of Skin Cancers with Partial Differential Alpha-Aminolevulinic Acid.